Hundreds of women have filed Paragard IUD lawsuits claiming that they were injured when a design defect in the popular IUD caused it to fracture during removal and leave foreign objects inside their bodies.
The Paragard lawsuits in the federal courts have been consolidated into a new Paragard MDL in the Northern District of Georgia. In this post, we will speculate on how much these Paragard lawsuits might be worth if the litigation is resolved in a global settlement with the manufacturers.
This post speculates about Zantac lawsuit settlement amounts. Yes, it is impossible to know what the average compensation payout might be in the Zantac litigation at this stage.
But projecting settlement amounts is what stock analysts and shareholders for Sanofi-Aventis, Boehringer Ingelheim, Pfizer, and GlaxoSmithKline are already doing and baking those costs into the stock price. Plaintiffs’ Zantac lawyers can do this as well.
So this post will look at how much these Zantac lawsuits might eventually be worth based on comparisons to other mass tort settlements involving cancer.
Our lawyers have been involved in the 3M earplug claims from the beginning. Veterans calling us today are increasingly asking a new question: has the statute of limitations deadline passed to bring my 3M earplug lawsuit?
My stock answer is that you should move your case forward as quickly as possible but there likely will not be a statute of limitations problem. But the real answer is more complicated and that is what I want to explain to you today.
People who have developed Parkinson’s from Paraquat want to better understand the range of settlement amounts they can expect in their Paraquat lawsuit.
It is early in the Paraquat litigation so settlement compensation payouts are speculative. But we can look at other similar injuries to try to get a settlement range if plaintiffs’ lawyers are successful, as expected, in this litigation. The expected Paraquat settlement amounts will fluctuate as the litigation progress. So our lawyers will continue to update this page. The last update was on September 20, 2021.
Yesterday afternoon, the first bellwether test trial in the hernia mesh litigation against C.R. Bard ended in a surprising loss for the plaintiff. The jury ruled in favor of the defense on all of the plaintiff’s product liability claims and award zero damages. In this post, we will look at how this happened and explain why it won’t have much impact on the big picture outcome of the hernia mesh litigation.
Utah resident Steven Johns underwent abdominal hernia repair surgery back in 2015. As part of the procedure, Mr. Johns’ surgeon implanted a Ventralight ST hernia mesh patch to help support and strengthen the surgically repaired muscle tissue. The Ventralight is part of a new line of permanent hernia mesh patches designed and manufactured by C.R. Bard Inc. (“Bard”).
Medical device company C.R. Bard Inc. is currently defending over 12,000 lawsuits alleging that its hernia mesh devices were defective and resulted in injuries and complications for thousands of hernia surgery patients.
This post will provide a brief historical overview of the hernia mesh lawsuits against C.R. Bard and look at the current status of the Bard hernia mesh class-action MDL as of September 2021.
Tasigna is a relatively new drug developed by Novartis for the treatment of leukemia. Not long after Tasigna was released in the U.S., evidence emerged indicating that Tasigna could cause a dangerous condition called atherosclerosis (narrowing of the blood arteries to the heart).
Plaintiffs’ lawyers claim that Novartis knew or should have known about this dangerous side-effect, but failed to include a warning in the prescribing information.
Users of Tasigna who suffered vascular damage from this undisclosed side-effect may be entitled to compensation for their injuries. Novartis has already been sued in a growing number of Tasigna lawsuits and a new “class-action” MDL has been created for consolidated handling of the Tasigna cases.
On May 28, 2021, 3M won their first trial in the 3M earplug lawsuits. The jury found that an Ohio Army veteran’s tinnitus was not caused by 3M’s negligence in selling and distributing the Combat Arms earplugs. Plaintiffs came back three weeks later with a $1.7 million verdict in the Baker case.
As of September 9, 2021, this is the record:
Ethicon (a Johnson & Johnson subsidiary) is defending over 3,000 lawsuits alleging that the defective design of its Physiomesh® hernia mesh product caused serious complications and injuries for surgery patients who had it implanted inside them.
The Ethicon Physiomesh hernia mesh lawsuits have been pending for 4 years and progress was significantly delayed by COVID shutdowns in 2020.
In this post, we will take a brief look at the Ethicon Physiomesh lawsuits and the current status of the Physiomesh class-action MDL as of September 2021.
In this post, we will provide a status update on what’s happening in the Atrium C-Qur hernia mesh litigation.
The Atrium hernia mesh MDL (Atrium Medical Corp. C-Qur Mesh Products Liability Litigation) has over 2,500 cases consolidated in the U.S. District Court for New Hampshire. This is the smallest of the three hernia mesh MDLs that are currently pending around the country.
